Cargando…
Differences in clinical characteristics and outcomes between patients with grade 3a and grades 1–2 follicular lymphoma: a real-world multicenter study
BACKGROUND: The difference between clinical characteristics and outcomes between follicular lymphoma grade 1–2 (FL1-2) and FL3a defined pathologically remains unclear, resulting in uncertainty how to treat FL3a. However, it may be crucial for clinicians to discriminate grade 3a and grade 1–2 for pre...
Autores principales: | Zha, Jie, Chen, Qinwei, Ye, Jingjing, Yu, Haifeng, Yi, Shuhua, Zheng, Zhong, Xu, Wei, Li, Zhifeng, Ping, Lingyan, He, Xiaohua, Zhang, Liling, Li, Caixia, Xie, Ying, Chen, Feili, Sun, Xiuhua, Su, Liping, Zhang, Huilai, Fan, Liyuan, Lin, Zhijuan, Yang, Haiyan, Zhao, Weili, Qiu, Lugui, Li, Zhiming, Song, Yuqin, Xu, Bing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9901161/ https://www.ncbi.nlm.nih.gov/pubmed/36747226 http://dx.doi.org/10.1186/s40364-023-00462-z |
Ejemplares similares
-
Clinical features and outcomes of 1845 patients with follicular lymphoma: a real-world multicenter experience in China
por: Zha, Jie, et al.
Publicado: (2021) -
Revealing the evolution of the tumor immune microenvironment in follicular lymphoma patients progressing within 24 months using single-cell imaging mass cytometry
por: Liu, Long, et al.
Publicado: (2022) -
Follicular lymphoma grade 3B: low grade, high grade or should we skip the grade?
por: Mulvey, Erin, et al.
Publicado: (2023) -
Preclinical Evaluation of the HDAC Inhibitor Chidamide in Transformed Follicular Lymphoma
por: Zhong, Mengya, et al.
Publicado: (2021) -
Grading of follicular lymphoma using flow cytometry
por: Mourad, Walid A., et al.
Publicado: (2006)